Abuse of methylphenidate in Germany: data from spontaneous reports of adverse drug reactions
Maximilian Gahr, Roland Freudenmann, Christoph Hiemke, Markus Kolle, Carlos Schonfeldt-Lecuona (2014)
Psychiatry research 215(1), 252-254
Abstract
To retrieve insights into abuse/dependence of methylphenidate (MPH) in Germany, a query of a pharmacovigilance database was performed (observation interval: 1993 until 2012). From 1190 reports of any ADR related to MPH, n=23 (2%) cases of MPH abuse were identified (mean age 29 years; male sex 78%; mean daily MPH-dosage 111 ± 126.6 mg). As oral application was predominant (70%), the majority of reported cases of MPH abuse might be due to pharmacologic neuroenhancement.
Categories: ADHS bei Erwachsenen, ADHS bei Kindern, Medikamente
Keywords: Attention deficit hyperactivity disorder, Neuroenhancement, Pharmacovigilance